Depletion of Tgfbr2 in hepatocytes alleviates liver fibrosis and restores hepatic function in fibrotic mice
Journal of Digestive Diseases · 2023-01 · 24 (1) · 39-50
DOI: 10.1111/1751-2980.13161 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Digestive Diseases, online erschienen am 26.03.2023. Verfasst von Shu Qing Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China. Hauptthemen laut MEDLINE: Hepatocytes, Liver Cirrhosis, Receptor, Transforming Growth Factor-beta Type II. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objectives
Previous studies have demonstrated the pivotal role of transforming growth factor (TGF)‐β signaling in activating hepatic stellate cells during liver fibrosis. In this study we aimed to demonstrate the effects and underlying mechanism of TGF‐β signaling in hepatocytes on hepatic fibrogenesis.
Methods
Hepatocyte‐specific Tgfbr2 ‐knockout ( Tgfbr2 HKO ) mice were generated by AAV8‐TBG‐Cre injection via the tail vein of Tgfbr2 f/f mice. CCl 4 was injected intraperitoneally twice a week for 4 weeks to establish the fibrotic mouse model. The expression of the fibrogenesis markers was evaluated by immunohistochemistry, western blot, and real‐time polymerase chain reaction (PCR). RNA‐seq analysis was used to detect the transcriptional profiles of primary hepatocytes isolated from Tgfbr2 HKO mice and control mice.
Results
The expression of TβR2 ( Tgfbr2 ) was markedly upregulated in hepatocytes of the fibrotic liver. Tgfbr2 depletion in hepatocytes decreased the expressions of profibrogenic markers ( Col1a1 and Acta2 ) in the CCl 4 ‐treated fibrotic liver. RNA‐seq analysis revealed that Tgfbr2 deletion in hepatocytes significantly reduced the inflammatory response and suppressed epithelial–mesenchymal transition of hepatocytes accompanied by upregulation of the metabolic pathways during liver fibrosis. Moreover, the expressions of hepatocyte nuclear factors (HNFs), including Hnf4α , Foxa1 , Foxa2 , and Foxa3 , which are important for maintaining liver metabolism and homeostasis, were decreased in fibrotic livers and significantly increased after Tgfbr2 blockade.
Conclusion
Blocking the TGF‐β signaling pathway in hepatocytes reduces hepatic fibrosis and improves hepatic function in fibrotic livers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China.
ORCID-Profile: Wei Fen Xie
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, S. Q., Deng, X., Zhu, C. P., Cui, Y. L., Xie, W. F., & Zhang, X. (2023). Depletion of Tgfbr2 in hepatocytes alleviates liver fibrosis and restores hepatic function in fibrotic mice. Journal of Digestive Diseases, 24(1), 39-50. https://doi.org/10.1111/1751-2980.13161
Vancouver
Liu SQ, Deng X, Zhu CP, Cui YL, Xie WF, Zhang X. Depletion of Tgfbr2 in hepatocytes alleviates liver fibrosis and restores hepatic function in fibrotic mice. Journal of Digestive Diseases. 2023;24(1):39-50. doi:10.1111/1751-2980.13161
BibTeX
@article{Liu2023,
author = {Liu, Shu Qing and Deng, Xing and Zhu, Chang Peng and Cui, Ya Lu and Xie, Wei Fen and Zhang, Xin},
title = {Depletion of Tgfbr2 in hepatocytes alleviates liver fibrosis and restores hepatic function in fibrotic mice},
journal = {Journal of Digestive Diseases},
year = {2023},
volume = {24},
number = {1},
pages = {39--50},
doi = {10.1111/1751-2980.13161}
}
EUVIMED